Getty Images Holdings (NYSE:GETY) reported quarterly sales of $233.30 million which missed the analyst consensus estimate of $242.80 million by 3.91 percent.
Oppenheimer Maintains Outperform on Jasper Therapeutics, Lowers Price Target to $8
Oppenheimer analyst Jay Olson maintains Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and lowers the price target from $21 to $8.